Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an o... by Thatcher, Nick, Prof, Hirsch, Fred R, Prof, Luft, Alexander V, MD, Szczesna, Aleksandra, MD, Ciuleanu, Tudor E, Prof, Dediu, Mircea, MD, Ramlau, Rodryg, Prof, Galiulin, Rinat K, MD, Bálint, Beatrix, MD, Losonczy, György, Prof, Kazarnowicz, Andrzej, MD, Park, Keunchil, MD, Schumann, Christian, Prof, Reck, Martin, MD, Depenbrock, Henrik, MD, Nanda, Shivani, MS, Kruljac-Letunic, Anamarija, PhD, Kurek, Raffael, MD, Paz-Ares, Luis, MD, Socinski, Mark A, Prof

Get full text

TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, p... by Quoix, Elisabeth, Prof, Lena, Hervé, MD, Losonczy, Gyorgy, Prof, Forget, Frédéric, Prof, Chouaid, Christos, Prof, Papai, Zsolt, Prof, Gervais, Radj, MD, Ottensmeier, Christian, Prof, Szczesna, Aleksandra, Prof, Kazarnowicz, Andrzej, MD, Beck, Joseph T, MD, Westeel, Virginie, Prof, Felip, Enriqueta, Prof, Debieuvre, Didier, MD, Madroszyk, Anne, MD, Adam, Julien, MD, Lacoste, Gisèle, MD, Tavernaro, Annette, MSc, Bastien, Bérangère, MSc, Halluard, Céline, MSc, Palanché, Tania, PhD, Limacher, Jean-Marc, MD

Get full text

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updat... by Goldman, Jonathan W, MD, Dvorkin, Mikhail, MD, Chen, Yuanbin, MD, Reinmuth, Niels, MD, Hotta, Katsuyuki, Prof, Trukhin, Dmytro, MD, Statsenko, Galina, MD, Hochmair, Maximilian J, MD, Özgüroğlu, Mustafa, Prof, Ji, Jun Ho, MD, Garassino, Marina Chiara, MD, Voitko, Oleksandr, MD, Poltoratskiy, Artem, MD, Ponce, Santiago, MD, Verderame, Francesco, MD, Havel, Libor, MD, Bondarenko, Igor, Prof, Każarnowicz, Andrzej, MD, Losonczy, György, Prof, Conev, Nikolay V, MD, Armstrong, Jon, MSc, Byrne, Natalie, BSc, Thiyagarajah, Piruntha, MD, Jiang, Haiyi, MD, Paz-Ares, Luis, Prof

Get full text

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled p... by Paz-Ares, Luis, Dr, Mezger, Jörg, Prof, Ciuleanu, Tudor E, Prof, Fischer, Jürgen R, MD, von Pawel, Joachim, MD, Provencio, Mariano, Prof, Kazarnowicz, Andrzej, MD, Losonczy, György, Prof, de Castro, Gilberto, MD, Szczesna, Aleksandra, MD, Crino, Lucio, MD, Reck, Martin, MD, Ramlau, Rodryg, Prof, Ulsperger, Ernst, MD, Schumann, Christian, MD, Miziara, Jose Elias A, MD, Lessa, Álvaro E, MD, Dediu, Mircea, MD, Bálint, Beatrix, PhD, Depenbrock, Henrik, MD, Soldatenkova, Victoria, MSc, Kurek, Raffael, MD, Hirsch, Fred R, Prof, Thatcher, Nick, FRCP, Socinski, Mark A, Prof

Get full text